Beth Mole is a Senior Health Reporter at Ars Technica. With a Ph.D. in microbiology and over a decade of experience, she specializes in infectious diseases, public health, and microbes, while also covering topics related to diet and nutrition, FDA regulations, and food safety. Her work has been featured in notable publications such as WIRED, Nature, and Science News.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Beth Mole's coverage is heavily focused on healthcare and pharmaceuticals, with a significant emphasis on citing data, government announcements, and breaking news. Her articles often touch upon topics such as the pharmaceutical industry, FDA regulations, AI in healthcare, public health issues, and scientific developments.
Given her extensive coverage of healthcare-related topics with an emphasis on citing data and government announcements, Beth would likely be interested in receiving pitches from experts who can provide insightful analysis backed by credible data. Additionally, individuals or organizations involved in groundbreaking scientific research or those closely following regulatory changes within the healthcare sector may also capture her attention.
Considering that Beth focuses on national (United States) content but covers global health topics like MDMA therapy for PTSD treatment evaluated by the FDA as well as antibiotic resistance research; she may also consider perspectives from international experts whose insights have implications beyond U.S. borders.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Officials denied refusing entry, but dodged questions on why Americans didn't return.
Doctors are angry and alarmed that preventive care could go the way of vaccines. Health and Human Services (HHS) Secretary Robert F.
By: Beth Mole
8 pts Top medical groups are outraged and alarmed that anti-vaccine Health Secretary Robert F. Kennedy Jr. has fired two leaders of an influential panel that makes recommendations and sets insurance coverage for preventive care—such as mammograms, colonoscopies, statin use, and depression screening. On Wednesday,…
Ebola outbreak risk level increased as deaths reach 177 with nearly 750 cases.
Trump official asked CDC staff to volunteer to screen travelers at airports.
By: Beth Mole
13 pts The Ebola outbreak in the Democratic Republic of the Congo continues to spread wildly, outpacing the international response efforts sprinting to catch up to the deadly Bundibugyo virus strain. The outbreak was first announced May 15 and is already the third largest recorded. The World Health Organization's…
By: Beth Mole
The interim Phase I trial data was only from 35 people, but results look good so far.
By: Beth Mole
20 pts An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a positive start in an early clinical trial. Researchers running a Phase I safety trial for the drug, dubbed VERVE-102, published interim results from just 35 patients this week in the New…
About 1 in 5 cases were hospitalized and most of those developed complications. Measles rash on the body of a child.
The US has previously built specialized facilities just for this purpose.
